Intended for healthcare professionals

Corrections

India’s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1232 (Published 04 March 2015) Cite this as: BMJ 2015;350:h1232